Filing Details

Accession Number:
0001415889-25-006085
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-28 21:05:06
Reporting Period:
2025-02-26
Filing Date:
2025-02-28
Accepted Time:
2025-02-28 21:05:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1646649 Jonathan Sheena C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-02-26 50 $155.81 263,439 No 4 S Direct
Common Stock Disposition 2025-02-26 200 $157.80 263,239 No 4 S Direct
Common Stock Disposition 2025-02-26 580 $159.24 262,659 No 4 S Direct
Common Stock Disposition 2025-02-26 1,280 $161.04 261,379 No 4 S Direct
Common Stock Disposition 2025-02-26 590 $162.06 260,789 No 4 S Direct
Common Stock Disposition 2025-02-26 64 $155.66 44,718 No 4 S Indirect By Caraluna 1 Trust
Common Stock Disposition 2025-02-26 296 $158.77 44,422 No 4 S Indirect By Caraluna 1 Trust
Common Stock Disposition 2025-02-26 704 $160.76 43,718 No 4 S Indirect By Caraluna 1 Trust
Common Stock Disposition 2025-02-26 336 $161.58 43,382 No 4 S Indirect By Caraluna 1 Trust
Common Stock Disposition 2025-02-26 100 $162.64 43,282 No 4 S Indirect By Caraluna 1 Trust
Common Stock Disposition 2025-02-26 72 $155.66 44,710 No 4 S Indirect By Caraluna 2 Trust
Common Stock Disposition 2025-02-26 292 $158.88 44,418 No 4 S Indirect By Caraluna 2 Trust
Common Stock Disposition 2025-02-26 744 $160.85 43,674 No 4 S Indirect By Caraluna 2 Trust
Common Stock Disposition 2025-02-26 296 $161.64 43,378 No 4 S Indirect By Caraluna 2 Trust
Common Stock Disposition 2025-02-26 96 $162.64 43,282 No 4 S Indirect By Caraluna 2 Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect By Caraluna 1 Trust
No 4 S Indirect By Caraluna 1 Trust
No 4 S Indirect By Caraluna 1 Trust
No 4 S Indirect By Caraluna 1 Trust
No 4 S Indirect By Caraluna 1 Trust
No 4 S Indirect By Caraluna 2 Trust
No 4 S Indirect By Caraluna 2 Trust
No 4 S Indirect By Caraluna 2 Trust
No 4 S Indirect By Caraluna 2 Trust
No 4 S Indirect By Caraluna 2 Trust
Footnotes
  1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.
  2. These shares were sold in multiple transactions at prices ranging from $157.4150 to $158.1900 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  3. These shares were sold in multiple transactions at prices ranging from $158.72 to $159.58 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  4. These shares were sold in multiple transactions at prices ranging from $160.5300 to $161.4450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  5. These shares were sold in multiple transactions at prices ranging from $161.64 to $162.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  6. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
  7. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
  8. These shares were sold in multiple transactions at prices ranging from $158.33 to $159.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  9. These shares were sold in multiple transactions at prices ranging from $160.2550 to $161.2500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  10. These shares were sold in multiple transactions at prices ranging from $161.29 to $161.83 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  11. These shares were sold in multiple transactions at prices ranging from $158.6850 to $159.2500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  12. These shares were sold in multiple transactions at prices ranging from $160.43 to $161.29 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  13. These shares were sold in multiple transactions at prices ranging from $161.4750 to $161.8200 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote